Drug repurposing

Demyelination of neuron
#ALS #Drug repurposing #LifeArc #Medicines Discovery Catapult #MND Association #Motor neurone disease #Neuroscience

New guiding principles to overcome barriers to MND drug discovery

New guidance for the motor neuron disease (MND) drug discovery community has been published to ensure that future drug discovery and development efforts have the best chance of successfully translating from the lab to the clinic. The whitepaper ‘Guiding principles for drug discovery and development in… Read More

#News #Trending News

#Drug delivery #Drug development #Drug discovery #Drug repurposing #Microbiome #Mucoadhesive drug delivery #Pharmaceutical industry #Synthetic biology

New podcast: Outside the box thinking for drug discovery success

This is the latest episode of the free DDW narrated podcast, “Outside the box thinking for drug discovery success”, which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Stanford researchers construct the most complete synthetic microbiome, … Read More

#News

Medical professional examining mammogram
#Breast cancer #Drug repurposing #Hormone therapy #MHRA #Oncology #UK

UK women to benefit from drug to prevent breast cancer

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised a new indication for anastrozole, to prevent breast cancer in post-menopausal women at moderate or high risk of developing the disease. The hormone treatment was already authorised for use in the treatment of breast cancer… Read More

#News #Trending News

Warfarin
#Cancer research #Columbia University #Drug repurposing #Oncology

Warfarin could be repurposed as a potent cancer drug

A new study has shown that blood thinner warfarin could also treat cancer, as it stops tumours from interfering with a self-destruct mechanism that cells initiate when they detect mutations or other abnormalities (ferroptosis). The research by Columbia University researchers was conducted in human cells and… Read More

#Cancer Research #News #Trending News

Drug discovery illustration
#Covid-19 #Drug repositioning #Drug repurposing #Events #Paediatrics #Pharmacology #Rare disease #World Congress of Basic & Clinical Pharmacology

Drug repurposing: The benefits, risks and what we learned from Covid-19

What are benefits of drug repurposing and why do clinical drug trials so often fail? Diana Spencer summarises the key messages from the ‘Drug Repurposing: Challenges and Opportunities’ Symposium held at the 19th World Congress of Basic & Clinical Pharmacology (WCP) 2023. The Drug Repurposing symposium at WCP 2023 was… Read More

#Exclusive Content

Doctor writing a prescription
#Drug repurposing #EMA #FDA #MHRA #Regulatory #Unlicensed drug

Unlicensed and off-label drugs: What do we know?

Following the death of a cancer patient after they were given an unlicensed drug, Diana Spencer unpacks the practice of prescribing unlicensed and off-label medicines. This month, a cancer patient died and three others were hospitalised in the UK after they were administered an unlicensed version of the chemotherapy drug… Read More

#Exclusive Content #Regulatory

MRI showing glioblastoma
#Brain #Cancer research #Drug repurposing #Neuroscience #Oncology

FDA-approved drug sensitises brain cancer cells to radiotherapy

Researchers have discovered a clinical drug that sensitises glioblastoma (GBM) cells to radiotherapy and could replace the current standard of care.  Scientists from Korea and the US have unveiled the mechanism of radioresistance in GBM cells, identifying therapeutic targets to overcome radioresistance.  GBM is a… Read More

#Cancer Research #News

Clinical research
#Biomedical research #Drug discovery #Drug repurposing #LifeArc #Medical Research Council #Medicines repurposing

Toolkit launched for medicines repurposing

A free online toolkit has been launched to help researchers navigate the opportunities and challenges of repurposing medicines for different indications. The toolkit was created by medical research charity LifeArc and the Medical Research Council (MRC). “Having learned the challenges of repurposing firsthand, I think this toolkit is enormously practical… Read More

#News

Woman doing clinical research
#Computational chemistry #Drug discovery #Drug repurposing #Idiopathic pulmonary fibrosis #Lung disease #Medicines repurposing #Preclinical investigations

Cancer drug shows promise in treating incurable lung disease 

Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF).   Saracatinib worked as well or better than two approved drugs at reducing tissue scarring in preclinical models of IPF according to the study published in the American Journal of… Read More

#News

#Drug repurposing #Pharmaceutical industry

Highs and lows of drug repurposing 

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong explores the rise of drug repurposing and the benefits and disadvantages it brings to drug discovery and development.  Drug repurposing, the act of finding new clinical targets for both approved and unapproved drugs, has emerged as a viable alternative… Read More

#Business & Investment #Exclusive Content #Opinion

#Drug discovery #Drug repurposing

Viagra can strongly suppress abnormal heart rhythms, finds study 

Scientists from the University of Manchester have found that the drug Viagra, used to treat sexual impotence, can strongly suppress abnormal heart rhythms known as arrythmias in sheep.  The British Heart Foundation funded study, published in Circulation Research, could have important implications on the management of the… Read More

#News

#Cancer #Cancer research #Clinical trials #Drug repurposing

Aspirin trialled as potential treatment for aggressive breast cancer 

A new study is trialling whether giving aspirin alongside immunotherapy drug avelumab could improve its effectiveness for people affected by breast cancer.   The clinical trial is being funded by the Breast Cancer Now Catalyst Programme, which aims to accelerate progress in breast cancer research through innovation and collaboration. As… Read More

#Cancer Research #News #Trending News

#Cancer research #Covid-19 #Drug development #Drug discovery #Drug repurposing #Research

How this chemotherapy cancer drug can be used to fight Covid-19

Mount Sinai researchers have found that widely available and inexpensive drug targeting inflammatory genes have reduced morbidity and mortality in mice infected with SARS-CoV-2. Following its publication in Cell, and reporting by DDW, Megan Thomas spoke to Dr Ivan Marazzi, co-author of the study and associate professor in the Microbiology… Read More

#Editor's Choice #Exclusive Content #News

Covid-19
#Cancer #Cancer research #Covid-19 #Drug repurposing

Can this cancer drug treat severe cases of Covid-19?

Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory gene has reduced morbidity and mortality in mice infected with SARS-CoV-2. In a study published in Cell, the team reported that the drug, topotecan (TPT), inhibited the expression of inflammatory genes in the lungs of mice… Read More

#Covid-19 #News #Trending News

#Data #Drug development #Drug repurposing #Drug research

In vitro drug interaction data critical in drug repurposing

Listen to this article on the DDW Podcast: In the wake of Covid-19 interest in repurposing a drug for a different indication to the one it was developed for has been high. Madison Knapp, Marketing Communications Specialist, and Dr. Brian Ogilvie, Vice President of Scientific Consulting, SEKISUI XenoTech offer insight into… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News #Opinion